Better Data, Possible Relief, Fair Warning. Now Do the Work.

OPINION. This is a point-of-view piece, not news reporting. It relies only on facts reported, sourced and dated in this week's issue.

Independent orthopedic practices and ASCs in Texas keep hearing that the system will get more transparent and less burdensome. This week brought three reminders that a policy change on paper is not the same as relief in your practice. The work of turning it into results still falls on us.

Start with the good news. On Oct 5, CMS finalized an overhaul of the Transparency in Coverage rule. Payer in-network rate files and out-of-network allowed-amount files will be more standardized. That matters. In our view, rate data that is hard to compare mostly helps whoever already holds the numbers.

There is a trade-off: payers will report quarterly instead of monthly, so the data may be less current. We'll take it. Clean, comparable data four times a year beats messy data twelve times a year that nobody can use. The real question is whether practices will open these files. Standardization removes an excuse. It does not do the analysis for you. Walking into your next contract renewal without looking at the data is a choice.

Then there's UnitedHealthcare. UHC removed roughly 30% of its commercial prior-authorization requirements, effective Oct 1. A secondary summary says orthopedic codes are included. We have not verified that against UHC's own requirements document, and you shouldn't assume it either. A headline percentage is not a workflow change. Check every code you bill against the UHC document before your staff stops submitting requests. If the relief is real, take it. If it isn't, a denied claim is an expensive way to find out.

Finally, the Ambulatory Specialty Model. It is mandatory, and it is set to start Jan 1, 2027, less than three months from now. The Texas Medical Association has asked CMS to delay it, and Becker's ASC cites 614 Texas low-back-pain physicians in connection with the model. TMA is right to push. But practices that treat low back pain should not plan around the hope of a reprieve. Plan for Jan 1, and treat any delay as a bonus.

The common thread: each of these stories hands independent practices something (better data, possible relief, advance warning), and each one requires us to do the work to make it count. That's frustrating. It's also the job.

Our take: be fed up, but be ready. Pull the rate files. Verify the codes. Prepare for the model. Advocacy matters, and TMA's letter is part of that. But the practices that come out ahead in 2027 will be the ones that acted on what was in front of them in October.

This is an opinion piece. The facts it relies on are sourced and dated in this week's issue, including what we have not yet verified. Disagree? Email corrections@fedupandinformed.com.